SWOT ANALYSIS - LUPIN

S W O T

STRENGTHS WEAKNESSES OPPORTUNITIES THREATS

 STRENGTHS
S

 Market leadership in various drug

categories

Focus on strategy

Series of successful acquisitions

 WEAKNESSES

Higher dependence on foreign markets

Adherence to regulation

Labour overheads

Excessive importance to low growth segments

 OPPORTUNITIES

O Policy reform

Growing demand for biosimilars

Patient-driven health care

 THREATS

Competition from Ranbaxy and Cipla

Change of government policy